You are here


DIABETES runs in her family, but Logan Jansen has turned the situation around. Jansen said the deadly disease had given her the confidence to speak up and raise awareness.
Almost half of the nearly 10 million patients with active tuberculosis each year could potentially be cured with significantly shorter treatments than current guidelines recommend, a new analysis from UC San Francisco has found. The results suggest targeted therapies could be more effective in treating TB, which killed an estimated 1.3 million people around the world last year. 
For decades, doctors have been using antibiotics to fight tuberculosis (TB). And consistently, the microbe responsible for the disease, Mycobacterium tuberculosis, has been fighting back. When confronted with current drugs, such as the antibiotic rifamycin, the bacterium often mutates in ways that make it resistant to the treatment.
Millions of people with high blood sugar may be at greater risk of tuberculosis than previously thought, scientists said Friday, warning that diabetes and TB could combine to create the "perfect storm" of disease.
One of the larger challenges facing modern medicine is the rise of drug-resistant strains of bacteria. Overuse and overexposure to antibiotics during the past century have resulted in adapted strains of bacteria that are resistant to common antibiotics. Developing new drugs to combat drug-resistant strains is a difficult process, as scientists are often unsure exactly which cellular and genetic mechanisms contribute to the resistance of the new strain.
Tuberculosis, a severe lung infection that is curable but historically hard to detect, kills more people each year than HIV and Aids, and more than three times more than malaria.
A new simple method for testing stool samples using minimal equipment could identify thousands of children with tuberculosis (TB) and multidrug-resistant TB (MDR-TB) – drastically reducing the numbers of children under five dying from TB – announced today at the Union World Conference.
Protesting activists have demanded that the price for the blockbuster tuberculosis drug bedaquiline be slashed, at the opening of 49th Union World Conference on Lung Health, in the Netherlands.
A book telling the powerful stories of 13 child tuberculosis (TB) survivors and their families was launched at the 49th Union World Conference, to raise awareness of childhood TB and stigma.
For people like me who have devoted their entire medical careers to the fight against tuberculosis, there are finally some reasons to be optimistic about the fight against this scourge. This week, tuberculosis experts from 125 countries are gathering in Amsterdam, surrounded by a buzz of optimism that political leaders will finally come through on their commitments to fight the world’s most deadly infectious disease.